Cryotherapy & Oxaliplatin
The primary objective of this study is to determine if cryotherapy is beneficial to patients with colon cancer who are receiving oxaliplatin in the prevention of developing chemotherapy induced peripheral neuropathy.
- EligibilityCriteria: Inclusion Criteria:  Over the age of 18 years Willingness to participate in research Diagnosed with stage III colon cancer Chemotherapy naïve Planning to initiate Capecitabine + Oxaliplatin (CAPOX) chemotherapy regimen as part of standard of care.  Exclusion Criteria:  Pre-existing peripheral neuropathy Pre-existing diabetes Raynaud's disease Metabolic syndrome, including: Hypertension; Hypercholesterolemia; and Obesity (BSA > 2) Upper extremity amputees Specific autoimmune diseases: Guillain-Barre; Lupus; Rheumatoid arthritis; and Sjogren's syndrome - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult